| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,,
,,#,,#,
* Institut Pasteur, Unité de Régulation des Infections Rétrovirales, Paris, France;
INSERM Unité 802, Le Kremlin-Bicêtre, France;
Université Paris-Sud, Faculté de Médecine Paris XI, Le Kremlin-Bicêtre, France;
INSERM Unité 822, Hôpital Bicêtre, Le Kremlin-Bicêtre, France;
¶ AP-HP, CHU Necker-Enfants Malades, Laboratoire de Virologie, Paris, France;
|| Université Paris-Descartes, Faculté de Médecine, Paris, France;
# AP-HP, Hôpital Bicêtre, Service de Médecine Interne et Maladies Infectieuses, Le Kremlin-Bicêtre, France
"HIV controllers" (HICs) are rare individuals in whom HIV-1 plasma viral load remains undetectable without antiretroviral treatment. This spontaneous viral control in HICs is usually associated to strong functional HIV-specific CD8+ T cell responses. Accordingly, we have recently shown that CD8+ T cells from HICs strongly suppress ex vivo HIV-1 infection of autologous CD4+ T cells, suggesting a crucial role of this response in vivo. Knowledge of the mechanisms underlying the CD8+ T cell antiviral activity might help to develop effective T cell-based vaccines. In the present work, we further characterized the HIV-suppressive capacity of CD8+ T cells in 19 HICs. CD8+ T cells from 14 of the 19 HICs showed strong HIV-suppressive capacity ex vivo. This capacity was stable over time and was partially effective even on other primate lentiviruses. HIV-suppressive capacity of CD8+ T cells correlated strongly with the frequency of HIV-specific CD8+ T cells, and in particular of Gag-specific CD8+ T cells. We also identified five HICs who had weak HIV-suppressive CD8+ T cell capacities and HIV-specific CD8+ T cell responses. Among these five HICs, at least three had highly in vitro replicative viruses, suggesting that the control of viremia in these patients is not due to replication-defective viruses. These results, on the one hand, suggest the importance of Gag responses in the antiviral potency of CD8+ T cells from HICs and, on the other hand, propose that other host mechanisms may contribute to restraining HIV infection in HICs.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was financially supported by the Agence Nationale de Recherches sur le SIDA. S.Y.S. was supported by Korea Science and Engineering Foundation and the Institut Pasteur Korea.
2 Address correspondence and reprint requests to Dr. Asier Sáez-Cirión, Unité de Régulation des Infections Rétrovirales, Institut Pasteur, 25 rue du Dr Roux, 75725 Paris Cedex 15, France. E-mail address: asier.saez-cirion{at}pasteur.fr
3 M.S. and S.Y.S. contributed equally to this work.
4 Current address: INSERM Unité 841, Faculté de Médecine Henri Mondor, Créteil France.
5 Abbreviations used in this paper: HIC, HIV controller; moi, multiplicity of infection; PBMC, peripheral blood mononuclear cell; SFC, spot-forming cell.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
